Your session is about to expire
← Back to Search
Behavioral Intervention
Gamification for Medication Adherence in High Blood Pressure and Cholesterol
N/A
Waitlist Available
Led By Alexander Fanaroff, MD, MHS
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Prescribed 1 or 2 blood pressure medications and a statin medication for > 1 year
Has supply of medications at the time of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks (during study weeks 14-18)
Awards & highlights
Study Summary
This trial will study whether a gamification intervention can increase medication adherence in patients with hypertension and hyperlipidemia. The intervention will include social support and accountability measures.
Who is the study for?
This trial is for patients with high blood pressure and cholesterol who have struggled to take their medications regularly. They must own a smartphone, have had a recent blood pressure reading over 140 mm Hg, been on specific meds for over a year, and not taken them as prescribed in the last 6 months. Those with very high blood pressure or less than 6 months to live cannot join.Check my eligibility
What is being tested?
The study tests if adding game-like elements (gamification) to treatment, along with support from friends or family and reporting to doctors can help patients stick to their medication schedules better than just getting reminder texts.See study design
What are the potential side effects?
Since this trial focuses on improving medication adherence through gamification rather than testing new drugs, side effects are minimal and may include frustration or stress related to the use of technology or game mechanics.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been on 1 or 2 blood pressure meds and a statin for over a year.
Select...
I have my medications available now.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 weeks (during study weeks 14-18)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks (during study weeks 14-18)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
patient-reported adherence
Secondary outcome measures
Change in blood pressure over study duration
Medication possession ratio in weeks 14-18
Medication possession ratio over study duration
+1 moreOther outcome measures
Change in low density lipoprotein cholesterol
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Via the Way to Health platform, all patients will receive daily text messages asking about medication adherence for that day and twice weekly text messages asking if participants have measured blood pressure on that day.
Participants are entered into a game. Each week they receive 90 points. If they took their medications or checked their blood pressure the prior day, they keep their points, but if not, they lose 10 points. At the end of the week if they have at least 70 points they move up a level, but if not, they drop a level. Participants start in the middle of 5 levels.
Participants choose a support partner. At the start of the intervention, the study team holds a 3-way phone call with the participant and support partner to discuss ways they can help the participant meet their goal. The support partner gets a weekly email with the participant's progress.
Primary care physicians will receive a monthly email noting patients' self-reported adherence and blood pressure.
Group II: ControlActive Control1 Intervention
Via the Way to Health platform, all participants will receive daily text messages asking about medication adherence for that day and twice weekly text messages asking if participants have measured blood pressure on that day.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,019 Previous Clinical Trials
42,874,062 Total Patients Enrolled
Alexander Fanaroff, MD, MHSPrincipal InvestigatorUniversity of Pennsylvania
5 Previous Clinical Trials
4,352 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger